Detalles de la búsqueda
1.
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
Diabetologia
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38668761
2.
Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry.
Diabetologia
; 64(12): 2751-2761, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34494137
3.
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5).
Diabetes Obes Metab
; 23(2): 619-630, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33200487
4.
The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover trial.
Lancet Reg Health Eur
; 37: 100799, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362553
5.
Evaluating a systematic intensive therapy using continuous glucose monitoring and intermittent scanning glucose monitoring in clinical diabetes care: a protocol for a multi-center randomized clinical trial.
Front Clin Diabetes Healthc
; 4: 1247616, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37920192
6.
Design of a randomized cross-over study evaluating effects of carbohydrate intake on glycemic control in persons with type 1 diabetes.
Front Nutr
; 10: 1114317, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992911
7.
Evaluation of Reference Metrics for Continuous Glucose Monitoring in Persons Without Diabetes and Prediabetes.
J Diabetes Sci Technol
; 16(2): 373-382, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33100059
8.
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI.
Diabetes Care
; 44(1): 141-149, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33199470
9.
The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4).
Diabetes Care
; 43(9): 2017-2024, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641374
10.
HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.
BMJ
; 366: l4894, 2019 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31462492
11.
Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry.
Diabetes Care
; 42(8): 1530-1538, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171564
12.
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections.
Diabetes Ther
; 10(6): 2115-2130, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31564026
13.
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
Diabetes Technol Ther
; 20(4): 274-284, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29608107
14.
A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1 Diabetes.
Diabetes Technol Ther
; 19(3): 164-172, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28263665
Resultados
1 -
14
de 14
1
Próxima >
>>